ACAD
ACADIA Pharmaceuticals (ACAD) Stock Forecast
Review ACADIA Pharmaceuticals (ACAD) forecast with server-rendered company data, supporting context and links to related investor research.
- Short-term score
- 62
- Long-term score
- 71
- Overall BTI score
- 71
- Overall outlook
- Buy
ACADIA Pharmaceuticals (ACAD) Stock Forecast research
The ACAD forecast page separates the available short-term and long-term BTI outlooks. These scenarios summarize processed market and company data; they are not a promise of price performance or a substitute for current company guidance.
Use the forecast with the earnings, financials and valuation pages. Changes in results, interest rates, competition or market expectations can quickly make an earlier outlook less relevant.